Added value of working with GE Healthcare for your contrast media products
Looking for medical information?
Video Gallery
Our investment to continue to help meet your procedural needs
We have invested more than $240 million globally in the past five years12 to increase our capacity to deliver contrast media, and we will continue to invest in the future.
Both our primary API production and secondary filling and finishing capacity increased by more than 50% from 2013 to 2018.12
Our commitment to meeting your supply of contrast media
As the global demand for X-ray contrast media products has increased by more than 20% in the last three years13, we have strategically planned ways to help secure our supply of products.
Products and Equipment
- Data on file. GE Contrast Media Demand; 2019
- Grainger RG, Thomas AMK. In: Textbook of Contrast Media. Dawson P, Cosgrove DO, Grainger RG, eds. Oxford: Isis Medical Media; 1999.
- Widmark JM. Proc (Bayl Univ Med Cent). 2007;20:408-417.
- Almén T. Acta Radiol Suppl. 1995;399:2-18.
- Greco A et al. Radiology. 1990;176:451-456.
- Data on file. GE Healthcare Market Data; 2018
- Marshall G. Radiography. 2008;14:128-134.
- Gricar J et al. Radiol Manage. 2007;Sep/Oct:34-42.
- Dhaliwal H et al. Int J Life Cycle Assess. 2014;19:1965-1973.
- Data on file. GE Healthcare Inspection; 2018
- Data on file. GE Healthcare Quality; 2018.
- Data on file. GE Healthcare Market Data; 2018
- Data on file. GE Healthcare Investment Data; 2018.
API, active pharmaceutical ingredient.